drugset
drugset / Trial / NCT03827642

A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers

NCT03827642 ↗

Phase 1 Completed 24 enrolled INSYS Therapeutics Inc
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this study was to compare the bioavailability of two test formulations of Naloxone Nasal Spray with the reference formulations of Naloxone HCl IV and IM injection under fasted conditions.

Timeline

Start
2018-04-23
Primary completion
2018-05-06
Completion
2018-05-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule — Intranasal

Indications

No indication recorded.